• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估市售高通量 SARS-CoV-2 血清学检测试剂盒在血清学监测及相关应用中的性能。

Evaluation of Commercially Available High-Throughput SARS-CoV-2 Serologic Assays for Serosurveillance and Related Applications.

出版信息

Emerg Infect Dis. 2022 Mar;28(3):672-683. doi: 10.3201/eid2803.211885.

DOI:10.3201/eid2803.211885
PMID:35202525
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8888213/
Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) serosurveys can estimate cumulative incidence for monitoring epidemics, requiring assessment of serologic assays to inform testing algorithm development and interpretation of results. We conducted a multilaboratory evaluation of 21 commercial high-throughput SARS-CoV-2 serologic assays using blinded panels of 1,000 highly characterized specimens. Assays demonstrated a range of sensitivities (96%-63%), specificities (99%-96%), and precision (intraclass correlation coefficient 0.55-0.99). Durability of antibody detection was dependent on antigen and immunoglobulin targets; antispike and total Ig assays demonstrated more stable longitudinal reactivity than antinucleocapsid and IgG assays. Assays with high sensitivity, specificity, and durable antibody detection are ideal for serosurveillance, but assays demonstrating waning reactivity are appropriate for other applications, including correlation with neutralizing activity and detection of anamnestic boosting by reinfections. Assay performance must be evaluated in context of intended use, particularly in the context of widespread vaccination and circulation of SARS-CoV-2 variants.

摘要

严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)血清学调查可估算累计发病率以监测疫情,这需要评估血清学检测方法,以确定检测算法的开发,并解释检测结果。我们使用 1000 个经过高度特征化的样本的盲法检测组,对 21 种商业高通量 SARS-CoV-2 血清学检测方法进行了多实验室评估。检测方法的灵敏度范围为 96%-63%,特异性为 99%-96%,精密度为 0.55-0.99(组内相关系数)。抗体检测的持久性取决于抗原和免疫球蛋白靶标;与抗核衣壳和 IgG 检测相比,抗刺突和总 Ig 检测具有更稳定的纵向反应性。具有高灵敏度、特异性和持久抗体检测的检测方法非常适合血清学监测,但反应性逐渐减弱的检测方法也适用于其他应用,包括与中和活性的相关性以及通过再次感染检测记忆性增强。检测方法的性能必须在预期用途的背景下进行评估,特别是在广泛接种疫苗和 SARS-CoV-2 变体传播的背景下。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccfb/8888213/dda2a3d85c73/21-1885-F5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccfb/8888213/df2bbd492ddc/21-1885-F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccfb/8888213/81819329c942/21-1885-F2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccfb/8888213/4ebc0e9509d9/21-1885-F3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccfb/8888213/73e07dfbc143/21-1885-F4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccfb/8888213/dda2a3d85c73/21-1885-F5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccfb/8888213/df2bbd492ddc/21-1885-F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccfb/8888213/81819329c942/21-1885-F2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccfb/8888213/4ebc0e9509d9/21-1885-F3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccfb/8888213/73e07dfbc143/21-1885-F4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccfb/8888213/dda2a3d85c73/21-1885-F5.jpg

相似文献

1
Evaluation of Commercially Available High-Throughput SARS-CoV-2 Serologic Assays for Serosurveillance and Related Applications.评估市售高通量 SARS-CoV-2 血清学检测试剂盒在血清学监测及相关应用中的性能。
Emerg Infect Dis. 2022 Mar;28(3):672-683. doi: 10.3201/eid2803.211885.
2
Serological Assays Estimate Highly Variable SARS-CoV-2 Neutralizing Antibody Activity in Recovered COVID-19 Patients.血清学检测评估康复的新冠肺炎患者中高度可变的新冠病毒中和抗体活性。
J Clin Microbiol. 2020 Nov 18;58(12). doi: 10.1128/JCM.02005-20.
3
Severe Acute Respiratory Syndrome Coronavirus 2-Specific Antibody Responses in Coronavirus Disease Patients.严重急性呼吸综合征冠状病毒 2 特异性抗体反应在冠状病毒疾病患者中。
Emerg Infect Dis. 2020 Jul;26(7):1478-1488. doi: 10.3201/eid2607.200841. Epub 2020 Jun 21.
4
Validation of Commercial SARS-CoV-2 Immunoassays in a Nigerian Population.在尼日利亚人群中验证商业 SARS-CoV-2 免疫测定。
Microbiol Spectr. 2021 Oct 31;9(2):e0068021. doi: 10.1128/Spectrum.00680-21. Epub 2021 Oct 6.
5
Antibody kinetics and serologic profiles of SARS-CoV-2 infection using two serologic assays.使用两种血清学检测方法分析 SARS-CoV-2 感染的抗体动力学和血清学特征。
PLoS One. 2020 Oct 22;15(10):e0240395. doi: 10.1371/journal.pone.0240395. eCollection 2020.
6
Comparison of the Clinical Performances of the Abbott Alinity IgG, Abbott Architect IgM, and Roche Elecsys Total SARS-CoV-2 Antibody Assays.雅培 Alinity IgG、雅培 Architect IgM 和罗氏 Elecsys 总 SARS-CoV-2 抗体检测试剂的临床性能比较。
J Clin Microbiol. 2020 Dec 17;59(1). doi: 10.1128/JCM.02104-20.
7
Comparative Performance of Five Commercially Available Serologic Assays To Detect Antibodies to SARS-CoV-2 and Identify Individuals with High Neutralizing Titers.五种市售血清学检测方法检测 SARS-CoV-2 抗体的性能比较及识别高中和抗体滴度个体。
J Clin Microbiol. 2021 Jan 21;59(2). doi: 10.1128/JCM.02257-20.
8
Evaluation of four commercial, fully automated SARS-CoV-2 antibody tests suggests a revision of the Siemens SARS-CoV-2 IgG assay.评估四种商业化的全自动 SARS-CoV-2 抗体检测试剂盒提示需要对西门子 SARS-CoV-2 IgG 检测试剂盒进行修订。
Clin Chem Lab Med. 2021 Jan 15;59(6):1143-1154. doi: 10.1515/cclm-2020-1758. Print 2021 May 26.
9
Brief clinical evaluation of six high-throughput SARS-CoV-2 IgG antibody assays.六种高通量 SARS-CoV-2 IgG 抗体检测试剂盒的临床评估。
J Clin Virol. 2020 Aug;129:104480. doi: 10.1016/j.jcv.2020.104480. Epub 2020 Jun 1.
10
Diagnostic performance of four SARS-CoV-2 antibody assays in patients with COVID-19 or with bacterial and non-SARS-CoV-2 viral respiratory infections.四种 SARS-CoV-2 抗体检测试剂在 COVID-19 患者及细菌性和非 SARS-CoV-2 病毒呼吸道感染患者中的诊断性能比较。
Eur J Clin Microbiol Infect Dis. 2021 Sep;40(9):1983-1997. doi: 10.1007/s10096-021-04285-4. Epub 2021 Jun 9.

引用本文的文献

1
Detection of SARS-CoV-2 Reinfections Using Nucleocapsid Antibody Boosting.利用核衣壳抗体增强检测新型冠状病毒2型再感染
Emerg Infect Dis. 2025 May;31(5):958-966. doi: 10.3201/eid3105.250021.
2
Using SARS-CoV-2 nucleoprotein antibodies to detect (re)infection.使用严重急性呼吸综合征冠状病毒2核蛋白抗体检测(再)感染。
Epidemiol Infect. 2025 Feb 7;153:e38. doi: 10.1017/S095026882500010X.
3
Dynamics of SARS-CoV-2 infection over two epidemic waves in Manaus, Brazil: A serological study of seven thousand blood donors.巴西玛瑙斯两波疫情期间新型冠状病毒感染动态:对七千名献血者的血清学研究

本文引用的文献

1
SARS-CoV-2 antibody magnitude and detectability are driven by disease severity, timing, and assay.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)抗体的强度和可检测性受疾病严重程度、时间以及检测方法的影响。
Sci Adv. 2021 Jul 30;7(31). doi: 10.1126/sciadv.abh3409. Print 2021 Jul.
2
Sero-Prevalence of SARS-CoV-2 Antibodies in High-Risk Populations in Vietnam.越南高危人群中 SARS-CoV-2 抗体的血清阳性率。
Int J Environ Res Public Health. 2021 Jun 11;18(12):6353. doi: 10.3390/ijerph18126353.
3
SARS-CoV-2 antibody persistence in COVID-19 convalescent plasma donors: Dependency on assay format and applicability to serosurveillance.
PLoS One. 2025 Jan 15;20(1):e0308319. doi: 10.1371/journal.pone.0308319. eCollection 2025.
4
Seroprevalence of SARS-CoV-2 in wet market workers in Dhaka, Bangladesh in 2022.2022年孟加拉国达卡市湿货市场工作人员中新冠病毒血清阳性率。
IJID Reg. 2024 Nov 24;14:100497. doi: 10.1016/j.ijregi.2024.100497. eCollection 2025 Mar.
5
Risk reduction in SARS-CoV-2 infection and reinfection conferred by humoral antibody levels among essential workers during Omicron predominance.在奥密克戎毒株占主导期间,一线工作者体内体液抗体水平对降低新冠病毒感染及再感染风险的作用。
PLoS One. 2024 Dec 31;19(12):e0306953. doi: 10.1371/journal.pone.0306953. eCollection 2024.
6
Reply to "Vaccination caused underestimation of cumulative incidence of SARS-CoV-2 infection".对《疫苗接种导致严重急性呼吸综合征冠状病毒2感染累计发病率估计偏低》的回复
Microbiol Spectr. 2025 Feb 4;13(2):e0197924. doi: 10.1128/spectrum.01979-24. Epub 2024 Dec 16.
7
The Elecsys® Anti-SARS-CoV-2 and Elecsys® Anti-SARS-CoV-2 S antibody assays: Differentiating between vaccination and infection, and assessing long-term performance.罗氏 Elecsys® 抗 SARS-CoV-2 和 Elecsys® 抗 SARS-CoV-2 S 抗体检测:区分疫苗接种和感染,并评估长期性能。
PLoS One. 2024 Jul 18;19(7):e0305613. doi: 10.1371/journal.pone.0305613. eCollection 2024.
8
Detection of Nucleocapsid Antibodies Associated with Primary SARS-CoV-2 Infection in Unvaccinated and Vaccinated Blood Donors.检测未接种疫苗和接种疫苗的献血者中与原发性 SARS-CoV-2 感染相关的核衣壳抗体。
Emerg Infect Dis. 2024 Aug;30(8):1621-1630. doi: 10.3201/eid3008.240659. Epub 2024 Jul 9.
9
Bivalent mRNA COVID vaccines elicit predominantly cross-reactive CD4 T cell clonotypes.二价 mRNA COVID 疫苗主要诱导交叉反应性 CD4 T 细胞克隆型。
Cell Rep Med. 2024 Mar 19;5(3):101442. doi: 10.1016/j.xcrm.2024.101442. Epub 2024 Feb 28.
10
Performance of Three Anti-SARS-CoV-2 Anti-S and One Anti-N Immunoassays for the Monitoring of Immune Status and Vaccine Response.三种抗 SARS-CoV-2 抗 S 和一种抗 N 免疫分析用于监测免疫状态和疫苗反应的性能。
Viruses. 2024 Feb 14;16(2):292. doi: 10.3390/v16020292.
COVID-19 恢复期血浆供者中 SARS-CoV-2 抗体的持久性:依赖于检测方法和在血清学监测中的适用性。
Transfusion. 2021 Sep;61(9):2677-2687. doi: 10.1111/trf.16555. Epub 2021 Jun 20.
4
Estimating the Cumulative Incidence of SARS-CoV-2 Infection and the Infection Fatality Ratio in Light of Waning Antibodies.根据抗体衰减情况估计 SARS-CoV-2 感染的累积发病率和感染病死率。
Epidemiology. 2021 Jul 1;32(4):518-524. doi: 10.1097/EDE.0000000000001361.
5
Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus, Brazil.巴西玛瑙斯市 P.1 型 SARS-CoV-2 谱系的基因组学和流行病学研究。
Science. 2021 May 21;372(6544):815-821. doi: 10.1126/science.abh2644. Epub 2021 Apr 14.
6
Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity.多种 SARS-CoV-2 变异株逃避疫苗诱导的体液免疫中和作用。
Cell. 2021 Apr 29;184(9):2372-2383.e9. doi: 10.1016/j.cell.2021.03.013. Epub 2021 Mar 12.
7
Prevalence of SARS-CoV-2 in six districts in Zambia in July, 2020: a cross-sectional cluster sample survey.2020 年 7 月赞比亚六个地区 SARS-CoV-2 的流行情况:一项横断面聚类样本调查。
Lancet Glob Health. 2021 Jun;9(6):e773-e781. doi: 10.1016/S2214-109X(21)00053-X. Epub 2021 Mar 9.
8
Available COVID-19 serial seroconversion panel for validation of SARS-CoV-2 antibody assays.用于验证 SARS-CoV-2 抗体检测试剂盒的 COVID-19 系列血清学转换面板。
Diagn Microbiol Infect Dis. 2021 Jun;100(2):115340. doi: 10.1016/j.diagmicrobio.2021.115340. Epub 2021 Feb 6.
9
Selecting COVID-19 convalescent plasma for neutralizing antibody potency using a high-capacity SARS-CoV-2 antibody assay.使用高通量 SARS-CoV-2 抗体检测法选择 COVID-19 恢复期血浆的中和抗体效价。
Transfusion. 2021 Apr;61(4):1160-1170. doi: 10.1111/trf.16321. Epub 2021 Feb 18.
10
Resurgence of COVID-19 in Manaus, Brazil, despite high seroprevalence.尽管血清阳性率很高,巴西玛瑙斯仍出现新冠病毒的卷土重来。
Lancet. 2021 Feb 6;397(10273):452-455. doi: 10.1016/S0140-6736(21)00183-5. Epub 2021 Jan 27.